Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Budesonide + Formoterol
Symbicort Turbohaler
Not routinely available
SMC (1198/16)
10/10/2016
Indication
Treatment of patients with chronic obstructive pulmonary disease (COPD) with forced expiratory volume in 1 second (FEV1) 50% to 70% predicted normal (post bronchodilator) and an exacerbation history despite regular bronchodilator therapy.
Therapeutic Area
Respiratory system
Status Description
Not routinely available as not recommended for use in NHSScotland
Formulation
200 micrograms/6 Inhalation powder and 400 micrograms/12 Inhalation powder (Symbicort Turbohaler)
Comments
None
Link to Advice
Advice Published
10/10/2016
SMC Submission Type
Non submission
SMC Status
Not recommended